M

MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 0.7496 GBX -0.96% Market Closed
Market Cap: £130.7m

Wall St Price Targets

MXCT Price Targets Summary
MaxCyte Inc

Wall Street analysts forecast MXCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MXCT is 2.543 GBX with a low forecast of 1.4897 GBX and a high forecast of 3.1866 GBX.

Lowest Forecast
Price Target
1.4897 GBX
99% Upside
Average Forecast
Price Target
2.543 GBX
239% Upside
Highest Forecast
Price Target
3.1866 GBX
325% Upside
MaxCyte Inc Competitors:
Price Targets
AGCO
AGCO Corp
7% Upside
MRKR
Marker Therapeutics Inc
453% Upside
AAT
American Assets Trust Inc
-19% Downside
DREAMFOLKS
Dreamfolks Services Ltd
93% Upside
TES
Tesmec SpA
-30% Downside
CNTX
Context Therapeutics Inc
199% Upside
DVN
Devon Energy Corp
29% Upside

Revenue
Forecast

14% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
14% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 32%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MXCT's stock price target?
Price Target
2.543 GBX

According to Wall Street analysts, the average 1-year price target for MXCT is 2.543 GBX with a low forecast of 1.4897 GBX and a high forecast of 3.1866 GBX.

What is the Revenue forecast for MaxCyte Inc?
Projected CAGR
32%

Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 32%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett